No Survival Advantage After Double Umbilical Cord Blood (UCB) Compared to Single UCB Transplant in Children with Hematological Malignancy: Results of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0501) Randomized Trial

被引：1
|
作者：
Wagner, John E. [1 ]
Eapen, Mary [2 ]
Carter, Shelly L. [3 ]
Haut, Paul R. [4 ]
Peres, Edward [5 ]
Schultz, Kirk R. [6 ]
Thompson, Jason [3 ]
Wall, Donna A. [7 ]
Kurtzberg, Joanne [8 ]
机构：
[1] Univ Minnesota, Med Ctr, Pediat Blood & Marrow Transplant Program, Minneapolis, MN 55455 USA
[2] Med Coll Wisconsin, Milwaukee, WI 53226 USA
[3] EMMES Corp, Rockville, MD USA
[4] Indiana Univ, Dept Pediat, Div Hematol Oncol, Simon Canc Ctr, Indianapolis, IN 46204 USA
[5] Univ Michigan, Ann Arbor, MI 48109 USA
[6] Univ British Columbia, BC Childrens Hosp, Vancouver, BC V5Z 1M9, Canada
[7] Univ Manitoba, Winnipeg, MB, Canada
[8] Duke Univ, Med Ctr, Durham, NC USA
来源：
BLOOD | 2012年 / 120卷 / 21期
关键词：
D O I：
10.1182/blood.V120.21.359.359
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
359
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Allogeneic hematopoietic cell transplant (alloHCT) for hematologic malignancies in human immunodeficiency virus infected (HIV) patients (pts): Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0903)/AIDS Malignancy Consortium (AMC-080) trial.
    Ambinder, Richard F.
    Wu, Juan
    Logan, Brent
    Durand, Christine
    Shields, Ryan
    Popat, Uday R.
    Little, Richard F.
    Mcmahon, Deborah
    Mellors, John Watson
    Ayala, Ernesto
    Kaplan, Lawrence D.
    Noy, Ariela
    Howard, Alan
    Forman, Stephen J.
    Mendizabal, Adam M.
    Horowitz, Mary M.
    Navarro, Willis H.
    Alvarnas, Joseph C.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [22] Exercise and Stress Management Training For Patients Undergoing Autologous Or Allogeneic Hematopoietic Cell Transplantation. Results From Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0902
    Lee, Stephanie J.
    Le Rademacher, Jennifer
    Jim, Heather
    Syrjala, Karen L.
    Wingard, John R.
    Logan, Brent R.
    Wu, Juan
    Majhail, Navneet S.
    Wood, William A.
    Rizzo, J. Douglas
    Geller, Nancy L.
    Kitko, Carrie L.
    Faber, Edward A., Jr.
    Abidi, Muneer H.
    Slater, Susan E.
    Horowitz, Mary M.
    Jacobsen, Paul
    BLOOD, 2013, 122 (21)
  • [23] UNRELATED DONOR CORD BLOOD TRANSPLANTATION FOR CHILDREN WITH SEVERE SICKLE CELL DISEASE: RESULTS OF A PHASE II STUDY FROM THE BLOOD AND MARROW TRANSPLANT CLINICAL TRIALS NETWORK
    Kamani, N. R.
    Walters, M.
    Carter, S.
    Brochstein, J. A.
    Eapen, M.
    Levine, J. E.
    Logan, B.
    Panepinto, J.
    Parikh, S.
    Pulsipher, M.
    Schultz, K. R.
    Shenoy, S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S326 - S326
  • [24] PHASE II TRIAL OF NON-MYELOABLATIVE CONDITIONING AND PARTIALLY HLA-MISMATCHED (HLA-HAPLOIDENTICAL) BONE MARROW TRANSPLANTATION (BMT) FOR PATIENTS WITH HEMATOLOGIC MALIGNANCIES: RESULTS OF BLOOD AND MARROW TRANSPLANT CLINICAL TRIALS NETWORK (BMT CTN) PROTOCOL 0603
    Fuchs, E. J.
    Wu, J.
    Carter, S.
    Brunstein, C. G.
    Costa, L. J.
    Wingard, J. R.
    Jagasia, M.
    D'Elia, J.
    Eapen, M.
    O'Donnell, P., V
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S151 - S151
  • [25] Recommendations for Donor Human Leukocyte Antigen Assessment and Matching for Allogeneic Stem Cell Transplantation: Consensus Opinion of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN)
    Howard, C. Alan
    Fernandez-Vina, Marcelo A.
    Appelbaum, Frederick R.
    Confer, Dennis L.
    Devine, Steven M.
    Horowitz, Mary M.
    Mendizabal, Adam
    Laport, Ginna G.
    Pasquini, Marcelo C.
    Spellman, Stephen R.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (01) : 4 - 7
  • [26] Follistatin and Endoglin: Potential Biomarkers of Endothelial Damage and Non-Relapse Mortality after Myeloablative Allogeneic Hematopoietic Cell Transplantation in Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0402
    Newell, Laura F.
    Defor, Todd E.
    Cutler, Corey S.
    Verneris, Michael R.
    Blazar, Bruce R.
    Antin, Joseph H.
    Howard, Alan
    Wu, Juan
    MacMillan, Margaret L.
    Panoskaltsis-Mortari, Angela
    Weisdorf, Daniel J.
    Holtan, Shernan
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S73 - S74
  • [27] Follistatin and Endoglin: Potential Biomarkers of Endothelial Damage and Non-Relapse Mortality after Myeloablative Allogeneic Hematopoietic Cell Transplantation in Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0402
    Newell, Laura F.
    DeFor, Todd E.
    Cutler, Corey S.
    Verneris, Michael R.
    Blazar, Bruce R.
    Antin, Joseph H.
    Howard, Alan
    Wu, Juan
    MacMillan, Margaret L.
    Panoskaltsis-Mortari, Angela
    Weisdorf, Daniel J.
    Holtan, Shernan G.
    BLOOD, 2016, 128 (22)
  • [28] Effect of Sirolimus on Immune Reconstitution Following Myeloablative Allogeneic Stem Cell Transplantation: An Ancillary Analysis of a Randomized Controlled Trial Comparing Tacrolimus/Sirolimus and Tacrolimus/Methotrexate (Blood and Marrow Transplant Clinical Trials Network/BMT CTN 0402)
    Gooptu, Mahasweta
    Kim, Haesook T.
    Howard, Alan
    Choi, Sung W.
    Soiffer, Robert J.
    Antin, Joseph H.
    Ritz, Jerome
    Cutler, Corey S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (11) : 2143 - 2151
  • [29] Modeling Sitagliptin Effect on Dipeptidyl Peptidase IV (DPP4/CD26) Activity in Adults with Hematological Malignancies After Umbilical Cord Blood (UCB) Hematopoietic Stem Cell Transplant (HSCT)
    de Mendizabal, Nieves Velez
    Strother, Robert M.
    Messina-Graham, Steven
    Farag, Sherif S.
    Broxmeyer, Hal
    Bies, Robert R.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2013, 40 : S15 - S15
  • [30] The results of multicenter phase II, double-blind placebo-controlled trial of maintenance ixazomib after allogeneic hematopoietic cell transplantation (alloHCT) for high-risk multiple myeloma (MM) from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN 1302).
    Nishihori, Taiga
    Bashir, Qaiser
    Pasquini, Marcelo C.
    Martens, Michael
    Wu, Juan
    Alsina, Melissa
    Efebera, Yvonne Adeduni
    Gasparetto, Cristina
    Geller, Nancy
    Giralt, Sergio
    Koreth, John
    McCarthy, Philip L.
    Scott, Emma Catherine
    Stadtmauer, Edward Allen
    Vesole, David H.
    Hari, Parameswaran
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
12345